Thursday, May 7, 2026

North Korea’s AI Strategy: How Kim Jong Un Plans to Use AI for National Survival in 2026

North Korea views AI as vital for regime survival, planning to institutionalize it as a national priority at the upcoming Party Congress.

Copilot to Power Voice and Learning Functions in Samsung’s 2025 Screen Lineup

Samsung's 2025 TVs and monitors will feature Microsoft's AI, Copilot, enhancing user interaction and personal learning experiences.

Hyundai Motor Group’s Chung Reaffirms $26 Billion U.S. Investment, Bets on Robotics and Hydrogen

Hyundai's Chung Euisun outlines a $26B U.S. investment by 2028, focusing on robotics, AI, and hydrogen for future growth.

Health

CG Bio Group Launches Acellular Dermal Matrix-based Product Reallo Inject Fine

CG Bio launches Reallo Inject Fine, an acellular dermal matrix product, enhancing usability for medical professionals and expanding applications.

Ceragem Launches Global Standard for AI Home Healthcare, Accelerates Data Platform Push

Ceragem's new ISO/IEC report sets international standards for integrating home healthcare devices, focusing on user well-being and safety.

Hugel Participates AMWC ASIA & TDAC 2026 at the Taipei International Convention Center, Taiwan

Hugel targets Taiwan's aesthetic market, showcasing products at AMWC ASIA & TDAC 2026, while expanding in Indonesia with educational programs.

L&K BioMed Showcases Innovative Products at the AANS Conference in Texas

L&K BioMed showcased its products at the AANS conference, receiving positive feedback and interest for its cervical products, aiming to expand in the U.S. market.

Seers Signs $14.7 Million Contract with UAE to Supply 105,000 Units over 3 Years

Seers signs a major deal for mobiCARE devices in the UAE, aiming for 50% growth and expansion into Vietnam and beyond.
Latest

South Korea Launches $36 Million Medical AI Testbed Program for Real-World Clinical Trials

South Korea launches a $36M initiative for medical AI testing, supporting SMEs and startups in real-world healthcare applications.

GIST’s Breakthrough in Gene Diagnosis: A Game-Changer for Cancer and Infectious Disease Testing

GIST unveils a versatile genetic diagnostic platform, enhancing detection across diseases while simplifying design and improving efficiency.

South Korea to Lead Global Digital Healthcare Standardization Efforts

Asia is poised to lead in digital healthcare standardization, hosting an ISO meeting to enhance global interoperability in health informatics.

Eli Lilly’s New Weight Loss Pill Foundayo: A Game Changer in the GLP-1 Market?

The FDA has approved Eli Lilly's oral obesity drug Foundayo, enhancing competition in the weight loss market with flexible dosing.

LG Chem’s FMC-220: A Breakthrough Cancer Drug Targeting the p53 Y220C Mutation

LG Chem secures exclusive rights to FMC-220, a cancer drug targeting the p53 Y220C mutation, aiming for Phase 1 trials.

AITRICS Achieves MDSAP Certification: What This Means for Global Medical Device Standards

AITRICS gains MDSAP certification, enhancing its global market entry and demonstrating compliance with international quality standards.

SANDRO Dual 2026: The Next Big Thing in Laser Hair Removal Approved by Japan and Taiwan

Wontech's SANDRO Dual 2026 laser device gains certifications in Japan and Taiwan, enhancing its global market presence in cosmetic procedures.

Sam Chun Dang Pharm Signs 100 Million USD Licensing Deal for Oral Generics of Rybelsus and Wegovy

Sam Chun Dang Pharm secures a U.S. licensing deal for generic diabetes and obesity medications, valued at $100 million.

Seragem’s Groundbreaking Hybrid Simulation Technology: What You Need to Know About Its Impact on Medical Devices

Ceragem Clinical's human simulation model enhances healthcare device efficiency, published in Annals of Biomedical Engineering.

Samsung Biologics Wins “Sustainability Leadership” at CDMO Awards: What This Means for the Future of Biopharma

Samsung Biologics wins the Sustainability Leadership award, marking a 13-year streak and highlighting its commitment to sustainable practices.

How Long-Term Use of Anticholinergic Medications Increases Fracture Risk by 65% in Seniors

A study reveals older adults on long-term medications face a 43% higher fracture risk, emphasizing the danger of anticholinergic drugs.

KIMES 2026: Record-Breaking Medical Expo Achieves 2.3 Trillion USD in Domestic Deals!

KIMES 2026 set attendance records with 75,003 visitors, generating 1.5 billion USD in domestic consultations and 450 million USD in exports.

GC Cell’s CAR-NK: Revolutionizing Solid Tumor Treatment with New Patent

GC Cell has patented an immunotherapy targeting solid tumors using its CAR-NK platform, aiming for safer, cost-effective treatments.

Celltrion Launches Omlyclo in Brazil: How This First Mover is Revolutionizing Autoimmune Treatment

Celltrion launched Omlyclo in Brazil, aiming to boost market penetration and strengthen ties with local medical professionals.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.